Sept. 6, 2009 -- Researchers in the U.K. and France have found three genes that make Alzheimer's disease more likely when certain mutations are present.
The genes -- which are called CLU, CR1, and PICALM -- may make good targets for new Alzheimer's disease treatments, the scientists report online in Nature Genetics.
The genes were found by comparing DNA from thousands of Europeans and Americans with and without Alzheimer's disease.
For instance, in July 2008, another team of researchers reported that a gene called TOMM40 may be a strong predictor of Alzheimer's disease.
Julie Williams, PhD, is a professor of neuropsychological genetics at Cardiff University in the U.K. She was one of the researchers involved in finding the new genes.
"Three of the risk genes -- APOE, CLU, and CR1 -- have roles in protecting the brain from damage. Perhaps the changes we see in these genes remove this protection or may even turn them into killers," Williams says in a statement posted on the Nature Genetics web site.
One day, the newly discovered genes may become part of a broad genetic test to predict Alzheimer's risk, but on their own, they wouldn't make a good gene test, researcher Michael Owen, PhD, notes in a news release. Owen directs Cardiff University's MRC Center for Neuropsychiatric Genetics and Genomics.
Owen says a larger study is being planned to look for more Alzheimer's gene targets.